Academia
The Akay Lab biomedical research team at the University of Houston is reporting an improvement on a microfluidic brain cancer chip previously developed in their lab.
The American Society of Addiction Medicine will honor physicians and important leaders in the field of addiction medicine at The ASAM 51st Annual Conference on April 2-5, 2020, in Denver, Colorado.
The use of antipsychotics is associated with increased risks of head and brain injuries among persons with Alzheimer’s disease, according to a recent study from the University of Eastern Finland.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Horizon Discovery Group plc, a global leader in the application of gene editing and gene modulation technologies, announces that it has exercised its option to exclusively license a novel Base Editing technology from Rutgers, The State University of New Jersey, for use in therapeutic, diagnostic and service applications.
First collaboration project focused on developing and commercializing lentiviral manufacturing system
Late Thursday, the U.S. Food and Drug Administration approved a new therapy to treat a rare mutation in patients with gastrointestinal stromal tumors.
BioMed X announced the start of a new joint research group in collaboration with Merck.
Clinicians and scientists from National Heart Centre Singapore, Duke-NUS Medical School’s Cardiovascular & Metabolic Disorders Programme (CVMD) and SingHealth Duke-NUS Academic Medical Centre (AMC)s’ discovery of a key driver of fibrosis and inflammation in human diseases is now moving rapidly toward the clinic.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
PRESS RELEASES